Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 4
2002 3
2003 2
2004 5
2005 5
2006 3
2007 8
2008 4
2009 6
2010 5
2011 5
2012 6
2013 4
2014 2
2015 1
2016 1
2017 1
2018 7
2019 9
2020 8
2021 11
2022 9
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Results by year

Filters applied: . Clear all
Page 1
Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up.
Danve-Szatanek C, Aymard M, Thouvenot D, Morfin F, Agius G, Bertin I, Billaudel S, Chanzy B, Coste-Burel M, Finkielsztejn L, Fleury H, Hadou T, Henquell C, Lafeuille H, Lafon ME, Le Faou A, Legrand MC, Maille L, Mengelle C, Morand P, Morinet F, Nicand E, Omar S, Picard B, Pozzetto B, Puel J, Raoult D, Scieux C, Segondy M, Seigneurin JM, Teyssou R, Zandotti C. Danve-Szatanek C, et al. Among authors: morfin f. J Clin Microbiol. 2004 Jan;42(1):242-9. doi: 10.1128/JCM.42.1.242-249.2004. J Clin Microbiol. 2004. PMID: 14715760 Free PMC article.
Immunogenicity and efficacy of          heterologous ChAdOx1-BNT162b2 vaccination.
Pozzetto B, Legros V, Djebali S, Barateau V, Guibert N, Villard M, Peyrot L, Allatif O, Fassier JB, Massardier-Pilonchéry A, Brengel-Pesce K, Yaugel-Novoa M, Denolly S, Boson B, Bourlet T, Bal A, Valette M, Andrieu T, Lina B; Covid-Ser study group; Cosset FL, Paul S, Defrance T, Marvel J, Walzer T, Trouillet-Assant S. Pozzetto B, et al. Nature. 2021 Dec;600(7890):701-706. doi: 10.1038/s41586-021-04120-y. Epub 2021 Oct 21. Nature. 2021. PMID: 34673755
Type I IFN immunoprofiling in COVID-19 patients.
Trouillet-Assant S, Viel S, Gaymard A, Pons S, Richard JC, Perret M, Villard M, Brengel-Pesce K, Lina B, Mezidi M, Bitker L, Belot A; COVID HCL Study group. Trouillet-Assant S, et al. J Allergy Clin Immunol. 2020 Jul;146(1):206-208.e2. doi: 10.1016/j.jaci.2020.04.029. Epub 2020 Apr 29. J Allergy Clin Immunol. 2020. PMID: 32360285 Free PMC article. No abstract available.
Novel targets for the development of anti-herpes compounds.
Greco A, Diaz JJ, Thouvenot D, Morfin F. Greco A, et al. Among authors: morfin f. Infect Disord Drug Targets. 2007 Mar;7(1):11-8. doi: 10.2174/187152607780090766. Infect Disord Drug Targets. 2007. PMID: 17346207 Review.
[Genotyping diagnosis of acyclovir resistant herpes simplex virus].
Frobert E, Thouvenot D, Lina B, Morfin F. Frobert E, et al. Among authors: morfin f. Pathol Biol (Paris). 2007 Dec;55(10):504-11. doi: 10.1016/j.patbio.2007.08.005. Epub 2007 Oct 24. Pathol Biol (Paris). 2007. PMID: 17920786 Review. French.
106 results